Skip to main content
Fig. 4 | BMC Medicine

Fig. 4

From: The impact of medication reviews by general practitioners on psychotropic drug use and behavioral and psychological symptoms in home-dwelling people with dementia: results from the multicomponent cluster randomized controlled LIVE@Home.Path trial

Fig. 4

Change in patient-general practitioner (GP) communication by medication reviews. Patient-GP communication as perceived by the informal caregivers stratified on whether medication reviews were conducted for people with dementia (n) during the first 6-month period of the LIVE@Home.Path trial. CGIC: Clinical Global Impression of Change, range −5–5, negative value: worsening, positive value: improvement. P values for difference in mean, marked * if <0.05, and 95% confidential interval by the unequal variances t-test

Back to article page